Fund Profile

Schroders Capital Global Innovation 16 June 2023

Disclaimer

This is a non-independent marketing communication commissioned by Schroder Investment Management. The report has not been prepared in accordance with legal requirements designed to promote the independence of investment research and is not subject to any prohibition on the dealing ahead of the dissemination of investment research.

Overview
INOV is on the next phase of its journey yet the discount still reflects legacy issues…
Overview

Schroders Capital Global Innovation Trust (INOV) has moved onto the next phase of its journey following a change to the investment policy. This has been marked with a name change from Schroder UK Public Private, as well as a change to the management team. Lead portfolio manager Tim Creed has now been joined by co-portfolio manager Harry Raikes. As a result of the change of policy, INOV will become a predominantly private equity vehicle, focussed on identifying long-term growth opportunities from a range of subsectors primarily within technology and healthcare industries and split across three sub-strategies: venture, growth, and life sciences (see Portfolio).

INOV remains on a wide Discount, though the board are taking steps to address this. Having completed their previous goal of reducing the trust’s gearing level, they have now made a commitment to utilising cash to conduct share buybacks, including using one quarter of any capital generated from the sale of legacy assets to buy shares back. On top of this, the board has introduced a continuation vote in 2025, and every subsequent five-year period, to offer investors the opportunity to wind up the trust should they wish.

The managers point to the independent valuation team having downgraded valuations of the trust’s holdings in order to factor in weakness in public equity markets which they believe may offer an effective ‘double discount’ on the trust (see Performance). The process of populating the portfolio with global, private companies with best-in-class offerings is underway which they believe marks the beginning of a new chapter for the trust.

Analyst's View

We believe the new approach could offer the managers an opportunity to turn a corner with INOV. Whilst long-term past performance has been disappointing, there are now 13 new investments in the Portfolio that have been made by the Schroders Capital team meaning the future prospects are going to be more significantly influenced by their decisions and their management. This team have 25 years of experience investing in private markets and have a track record that includes early investment in the likes of Google, Facebook, and YouTube. We believe this background could provide investors with encouragement that they are capable of identifying the next winners and helping turn around the performance of the trust.

We believe that the narrative of the trust’s Performance has been very linked to its legacy. The trust, under its previous guise, has been affected by well-publicised issues which led to disappointing performance. It is arguable now though that the current discount reflects the sentiment this caused, and that this is pricing in more than the fundamentals of how the underlying portfolio has fared.

Furthermore, we believe the changes to the Discount policy, including a focus on narrowing the discount through share buybacks and the introduction of a continuation vote, may offer a level of defensiveness for investors. We believe this could provide a limit to the downside in the next couple of years as the opportunity to wind the trust up gets closer, though also offers some optionality should the strategy evolution begin to bear fruit.

Bull

  • Portfolio has evolved from legacy management to identifying new private investments
  • Management is now fully under the experienced and specialist Schroders Capital team
  • Board has implemented a buyback policy and continuation vote to help narrow the discount

Bear

  • Performance has been challenging
  • Investors may dislike the performance fee though we note it will require a large turnaround for it to be earned
  • Early-stage investments are at high risk of failure
Continue to Portfolio

Fund History

04 Oct 2024 Results analysis: Schroders Capital Global Innovation
INOV’s managers have made progress in rebalancing the portfolio to high-growth potential private companies…
12 Jul 2024 Schroders Capital Global Innovation Trust - a focus on the life sciences portfolio
Capturing the innovative potential of global life sciences...
05 Apr 2024 Results analysis: Schroders Capital Global Innovation
Recent corporate activity could indicate INOV’s new strategy is working…
05 Jan 2024 Schroders Capital Global Innovation Trust: The journey so far
The recent name change of the trust provides a valuable opportunity to look back on the important steps forward that we have taken and reflect on the prospects that await...
17 Nov 2023 Don’t Panic!
Our analysts look for value against a backdrop of bombed out investment trust discounts…
08 Nov 2023 Once more into the breach?
With yawning discounts across the board, some sectors have been hit harder than others - our analysts think there could be value there for those with the sangfroid to fight for it...
16 Nov 2023 Schroders Capital Global Innovation
Harry Raikes
Rewatch this webinar which is part of our November online event 'Discounted opportunities in a tough market'...
Watch Recording
07 Jul 2023 Schroders Capital Global Innovation Trust: Where we’re looking to deploy private equity capital
Exploring the private equity company life cycle...
16 Jun 2023 Fund Analysis
INOV is on the next phase of its journey yet the discount still reflects legacy issues…
16 Dec 2022 Investment Trusts: opportunities in all market conditions
How are current market conditions impacting the Schroders investment trust range?
30 Nov 2022 Cry havoc!
Lessons from a year in which an already troubled world was savaged by the dogs of war...
01 Nov 2022 Fund Analysis
SUPP’s portfolio is maturing and evolving, yet trades on a discount of 46%...
View all

Welcome to Kepler Trust Intelligence

Please enter a valid email address
{{item.msg}}
Please enter a valid password
{{item.msg}}
Please enter a valid email address
{{item.msg}}
Please check your email. If an account exists you'll be sent instructions on how to reset your password.
To ensure that we are able to provide content which is appropriate for you, please tell us a little about yourself.
Please choose an option
{{item.msg}}
Please enter a company name
{{item.msg}}
Please enter a location name
{{item.msg}}
Please choose an option
{{item.msg}}
Please enter a platform
{{item.msg}}
Please choose an option
{{item.msg}}
Please enter a trust
{{item.msg}}
See benefits
A free Kepler Trust Intelligence account allows you to access premium content including the ‘Kepler View’ – our verdict on the trusts we cover – and historical research so you can see how our view has changed over time. An account also unlocks useful facilities like the ‘follow’ button which lets you keep track of the trusts you’re interested in and as a logged in user you can also download PDFs of our research, and choose the layout of the page you’re reading to suit your preference. We will not share your details unless you give us permission to do so, and we won’t bombard you with emails – we only send one a week.
Please select an option
{{item.msg}}
Please enter your first name
{{item.msg}}
Please enter your last name
{{item.msg}}
Please enter a valid email address
An account already exists with this email - have you forgotten your password?
{{item.msg}}
Please enter a valid password
{{item.msg}}
Please enter a valid password
{{item.msg}}
?
The information contained herein is not for distribution and does not constitute an offer to sell or the solicitation of any offer to buy any securities in the United States to or for the benefit of any United States person (being residents of the United States or partnerships or corporations organised under the laws thereof). The investment funds referred to herein have not been registered in the United States under the Investment Company Act of 1940 and units or shares of such funds are not registered in the United States under the Securities Act of 1933.
Please confirm
{{item.msg}}
Please select an option
{{item.msg}}
How will this information be used? Your answers help us to tailor our content to relevant investment trusts, and to ensure that the asset allocation and portfolio strategy research we produce is appropriate to our userbase.
Our Website uses Cookies Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean we can understand how you use our site. Some cookies have already been set. You can delete and block cookies, but parts of our site won’t work without them. By using our website you accept our use of cookies. For further information please refer to the Kepler Privacy Notice.
Need help?

One more thing...

Did you know, you can 'follow' individual trusts on Kepler Trust Intelligence? Use the functions below to set up alerts and we'll send you research and updates on your chosen trusts.

Suggested trusts to follow

Browse all funds
Need help?
Current Site Kepler Trust Intelligence is produced by the investment companies team at Kepler Partners and is the UK’s premier source of detailed qualitative research on investment trusts. Absolute Hedge is a market leading UCITS research database providing proprietary research on funds, themes and strategies in the UCITS space. Kepler Liquid Strategies is a Dublin domiciled UCITS fund platform featuring a number of best-of-breed fund managers. Kepler Partners is a corporate advisory and asset raising boutique specialising in the regulated funds market in Europe and investment trusts in the UK.